Crossmark

Analysis of the frequency of oncogenic driver mutations and correlation with clinicopathological characteristics in patients with lung adenocarcinoma from Northeastern Switzerland

Crossref DOI link: https://doi.org/10.1186/s13000-019-0789-1

Published Online: 2019-02-11

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Grosse, Alexandra

Grosse, Claudia

Rechsteiner, Markus

Soltermann, Alex
License Information

Text and Data Mining valid from 2019-02-11
More Information

Article History

Received: 13 November 2018

Accepted: 1 February 2019

First Online: 11 February 2019

Ethics approval and consent to participate

: The study was approved by the Cantonal Ethics Committee of Zurich (StV-No. 2009/14–0029). Formal patient consent was not required because of the retrospective study design.

: Not applicable

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below